Dr. Sarah Chen, MD, Internal Medicine, Board Certified
Lead Medical Reviewer
Licensed in: CA
Full profile →Loading content…
Medical Review Board
Every clinical claim, dosing guideline, side-effect description, and FDA-status reference on GLP1Zoom is reviewed by a licensed clinician before publication. Our 5-specialist Medical Review Board ensures editorial accuracy across endocrinology, bariatric medicine, cardiology, and clinical pharmacology.
5 specialist reviewers
Reviewer specialty matched to content topic. Drug interactions reviewed by PharmD; cardiovascular content reviewed by cardiologist; etc.
Dr. Marcus Patel, MD, FACE
Endocrinology · Type 2 Diabetes specialist · Clinical Reviewer
Dr. Patel is a board-certified endocrinologist (American Board of Internal Medicine, Endocrinology Diabetes & Metabolism subspecialty) and Fellow of the American College of Endocrinology.
Dr. Elena Rodriguez, MD, PhD
Bariatric Medicine · Surgical + Pharmacological Weight Loss · Clinical Reviewer
Dr. Rodriguez is a board-certified internal medicine physician with subspecialty board certification in Obesity Medicine (American Board of Obesity Medicine) plus PhD in Metabolic Physiology.
Review process
- Drafts are written by trained medical writers with pharmacy or clinical training.
- Every claim is sourced — we cite FDA labels, peer-reviewed journals, and manufacturer documents.
- A licensed reviewer with relevant specialty (matched to content topic) signs off before publication.
- Pages are revisited every 6 months minimum; pricing tables are refreshed monthly.
- Last reviewed dates are displayed on every drug, provider, and comparison page.
Independence + compensation
All Medical Review Board members are compensated on a flat-fee basis for their review time.They do not receive affiliate commissions, equity, or referral payments from any partner appearing on GLP1Zoom. Reviewers may flag content for revision or decline to approve content that does not meet evidentiary standards.
Editorial control — including which products to compare, how to rank them, and which to flag with FDA disclaimers — rests entirely with the GLP1Zoom editorial team, independent of partner financial relationships.
Have content concerns? If you spot inaccurate medical claims on any page, contact us through our editorial feedback channel. Reviewers respond within 5 business days; corrections are timestamped.
